Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs10176226 | chr2:178798249 | A/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10176232 | chr2:178798272 | A/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10180071 | chr2:178784980 | T/A | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10181377 | chr2:178782261 | A/G | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10182833 | chr2:178792763 | G/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10183144 | chr2:178793231 | C/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10186239 | chr2:178793916 | C/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10190066 | chr2:178787804 | T/C | 4.16E-5 | 492 | 30.8 | 31.93 | 20.48 | KM Plot |
PRAD | rs10190154 | chr2:178787890 | T/G | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10190805 | chr2:178784586 | A/G | 4.16E-5 | 493 | 30.8 | 31.93 | 20.48 | KM Plot |
PRAD | rs10191328 | chr2:178785158 | A/G | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10192990 | chr2:178795840 | G/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10193299 | chr2:178796105 | G/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10194612 | chr2:178786087 | A/G | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10195497 | chr2:178792993 | T/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |